US Stock MarketDetailed Quotes

TRDA Entrada Therapeutics

Watchlist
  • 13.900
  • -0.450-3.14%
Trading Mar 28 12:53 ET
467.06MMarket Cap-69500P/E (TTM)

About Entrada Therapeutics Company

Entrada Therapeutics, Inc. operates as a biotechnology company. It focuses on delivery of biomolecules into the cell to treat devastating diseases. The firm offers intracellular enzyme replacement therapy and protein-protein interaction inhibitors programs. The company focuses on creating and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to target and engage underlying drivers of diseases. Entrada Therapeutics was founded by Dehua Pei in September 22, 2016 and is headquartered in Boston, MA.

Company Profile

SymbolTRDA
Company NameEntrada Therapeutics
Listing Date10/29/2021
Issue Price20.00
Founded2016
CEOMr. Dipal Doshi
MarketNASDAQ
Employees159
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressOne Design Center Place
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-520-9158

Company Executives

  • Name
  • Position
  • Salary
  • Dipal Doshi
  • Chief Executive Officer, President and Director
  • 3.49M
  • Kory J. Wentworth
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Nerissa C. Kreher, M.D.
  • Chief Medical Officer
  • --
  • Nathan J. Dowden
  • Chief Operating Officer and President
  • 1.54M
  • Dr. Natarajan Sethuraman, PhD
  • Chief Scientific Officer
  • 1.62M
  • Dr. Kush M. Parmar, M.D.,PhD
  • Chairman of the Board
  • 123.44K
  • Dr. Peter S. Kim, PhD
  • Director
  • 81.94K
  • Dr. Bernhardt G. Zeiher
  • Director
  • --
  • Gina Chapman
  • Director
  • --
  • Mary T. Thistle
  • Independent Director
  • 96.94K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg